CRCM LP 对 MSLE 的持仓历史
Satellos Bioscience Inc. · 医疗保健
CRCM LP 在 Q3 2026 的 13F 申报中披露持有 MSLE(Satellos Bioscience Inc.)68,060 股,市值约 US$579K,约占其申报组合的 0.33%,在其申报持仓中市值排名第 13 位。 CRCM LP 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-12 · 来源: SEC EDGAR Form 13F-HR
CRCM LP 对 MSLE 的持仓演变
CRCM LP 于 Q3 2026 首次披露 MSLE 持仓:68,060 股(约 US$579K)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 68.06K | $578.51K | 新进 |
关于 MSLE 与 13F 数据
MSLE(Satellos Bioscience Inc.)属于医疗保健行业。我们追踪的基金中还有 28 只申报持有 MSLE,申报仓位最大的包括:Vivo Capital, LLC (US$6.3M), SPHERA FUNDS MANAGEMENT LTD. (US$5.1M), Stonepine Capital Management, LLC (US$3.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MSLE 的基金
- Vivo Capital, LLC 813.67K 股 · $6.33M · Q2 2026
- SPHERA FUNDS MANAGEMENT LTD. 652.59K 股 · $5.07M · Q2 2026
- Stonepine Capital Management, LLC 491.62K 股 · $3.72M · Q2 2026
- Avidity Partners Management LP 387.77K 股 · $3.01M · Q2 2026
- Saturn V Capital Management LP 350.00K 股 · $2.72M · Q2 2026
- Empery Asset Management, LP 107.10K 股 · $832.70K · Q2 2026
常见问题
How long has CRCM LP held MSLE?
CRCM LP has disclosed MSLE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is CRCM LP's current position in MSLE?
As of Q3 2026, CRCM LP holds 68.06K shares of MSLE (Satellos Bioscience Inc.), valued at $578.51K, representing 0.33% of its reported portfolio and ranking #13.
Has CRCM LP been buying or selling MSLE?
In the latest 13F filing (Q3 2026), CRCM LP newly opened its position in MSLE.
Which other funds hold MSLE?
Other major institutional holders of MSLE include Vivo Capital, LLC, SPHERA FUNDS MANAGEMENT LTD., Stonepine Capital Management, LLC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.